BlackRock Health Sciences Term Trust (NYSE:BMEZ) Portfolio Manager Christopher Accettella Acquires 1,190 Shares

BlackRock Health Sciences Term Trust (NYSE:BMEZ) Portfolio Manager Christopher Accettella bought 1,190 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Thursday, January 11th. The shares were acquired at an average price of 15.17 per share, with a total value of 18,052.30. Following the acquisition, the portfolio manager now directly owns 4,070 shares of the company’s stock, valued at 61,741.90. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

BlackRock Health Sciences Term Trust Price Performance

Shares of NYSE:BMEZ opened at 15.89 on Friday. The company’s 50-day moving average price is 15.86 and its two-hundred day moving average price is 15.53. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.59.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be issued a dividend of $0.176 per share. The ex-dividend date is Tuesday, October 15th. This represents a $2.11 annualized dividend and a yield of 13.29%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Almitas Capital LLC raised its stake in shares of BlackRock Health Sciences Term Trust by 89.3% during the 2nd quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock worth $27,063,000 after purchasing an additional 831,025 shares in the last quarter. Sessa Capital IM L.P. increased its holdings in BlackRock Health Sciences Term Trust by 27.1% during the second quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company’s stock worth $28,462,000 after buying an additional 395,288 shares during the last quarter. Sanctuary Advisors LLC acquired a new position in BlackRock Health Sciences Term Trust during the second quarter worth $3,179,000. Karpus Management Inc. raised its position in BlackRock Health Sciences Term Trust by 14.9% during the first quarter. Karpus Management Inc. now owns 1,398,681 shares of the company’s stock worth $22,924,000 after acquiring an additional 181,092 shares in the last quarter. Finally, Wolverine Asset Management LLC lifted its stake in BlackRock Health Sciences Term Trust by 1,569.0% in the second quarter. Wolverine Asset Management LLC now owns 190,839 shares of the company’s stock valued at $2,931,000 after acquiring an additional 179,405 shares during the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.